Showing 1 - 7 results of 7 for search 'Ronald Kong', query time: 0.08s Refine Results
  1. 1
    A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese Participants

    A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese Participants by Lan Gao, Diksha Kaushik, Kimberly Ingalls, Neil Smith, Ronald Kong

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers

    Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers by Lan Gao, Diksha Kaushik, Kimberly Ingalls, Sarah Milner, Neil Smith, Ronald Kong

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    In vitro cytochrome P450‐ and transporter‐mediated drug interaction potential of 6β‐hydroxy‐21‐desacetyl deflazacort-A major human metabolite of deflazacort

    In vitro cytochrome P450‐ and transporter‐mediated drug interaction potential of 6β‐hydroxy‐21‐desacetyl deflazacort-A major human metabolite of deflazacort by Jiyuan Ma, Brian Beers, Ravi Manohar, Stephen Roe, Joseph M. Colacino, Ronald Kong

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort

    Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort by Ronald Kong, Jiyuan Ma, Brian Beers, Diksha Kaushik, E Lin, Elizabeth Goodwin, Joseph Colacino, Francesco Bibbiani

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor

    A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor by Terri L. Morton, Oscar L. Laskin, Diksha Kaushik, Lucy Lee, Jiyuan Ma, Allan Kristensen, Kylie O'Keefe, Lee Golden, Matthew Klein, Ronald Kong

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren

    In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren by Ronald Kong, Jiyuan Ma, Seongwoo Hwang, Young‐Choon Moon, Ellen M. Welch, Marla Weetall, Joseph M. Colacino, Neil Almstead, John Babiak, Elizabeth Goodwin

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma

    Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma by Lan Gao, Diksha Kaushik, Brian A. Van Tine, Matthew A. Ingham, Steven Attia, Christian F. Meyer, Gary K. Schwartz, Pius Maliakal, John D. Baird, Jiyuan Ma, Rosemary Barrett, Dhiren D'Silva, Kylie O'Keefe, Ronald Kong

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: